Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach
정량적 단백질 학적 접근법을 사용하여 심한 코비드 -19의 혈청 예후 바이오 마커의 확인
Article
[키워드] acquisition
approach
best
Biomarkers
Cardiovascular disorders
characterized
CHI3L1
Clinical prognosis
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
COVID-19 prognosis
cytokine
cytokine signaling
determine
diagnostic
differential expression
differentially expressed
ELISA assay
evaluated
Health
help
identification
identify
IGFALS
IL-6
implicated
Ingenuity Pathway Analysis
interleukin
introduced
mass spectrometry
Necrosis
Patient
predicted
predictor
Prognosis
prognostic biomarker
Prognostic factor
Prognostic factors
Prognostic markers
progression
Protein
proteomic
Proteomic analysis
Quantitative
regulated
serum
Serum protein
serum proteins
severe COVID-19
severe COVID-19 patients
severe disease
severely ill COVID-19 patients
systemic inflammatory response
the disease
TNF
Treatment
Tumor
tumor necrosis
tumor necrosis factor
viral infection
with COVID-19
[DOI] 10.1038/s41598-021-98253-9 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-98253-9 PMC 바로가기 [Article Type] Article